Through the utilization of bioinformatics techniques, we inspected the relationship between ARIH2 expression and clinicopathological features, prognostic significance, and immune cell infiltration, explored the biological mechanism of ARIH2 in the progression of HCC, and assessed the feasibility of ARIH2 as a potential therapeutic target. The gene discussed is ARIH2; the disease is hepatocellular carcinoma.